Answers are grounded in this paper and cite their sources.
Klebsiella pneumoniae and Escherichia coli are major Enterobacterales pathogens that commonly harbor beta-lactamase enzymes conferring antimicrobial resistance. Conventional antimicrobial susceptibility testing (AST) is time-consuming and may delay appropriate antibiotic treatment, whereas nanopore sequencing enables real-time genetic analysis and may support rapid antimicrobial resistance detection at the point of care. This study evaluated the performance of nanopore sequencing for detecting ceftriaxone and carbapenem resistance in positive blood cultures containing K. pneumoniae or E. coli . In this cross-sectional descriptive study, positive blood culture samples yielding K. pneumoniae or E. coli were analyzed. Bacterial DNA was extracted and sequenced in its native form using the PromethION nanopore platform to detect antimicrobial resistance genes, and sequencing-based predictions were compared with routine blood culture results and standard AST. A total of 62 K. pneumoniae and 96 E. coli samples met the inclusion criteria for DNA extraction and sequencing. Simulated real-time analysis showed that the optimal condition for detecting third-generation cephalosporin and carbapenem resistance genes was approximately 1 h of sequencing, using a sequence divergence threshold of <0.001 against the antimicrobial resistance gene database. For third-generation cephalosporin resistance, sensitivity was 87.0% (95% CI: 79.5%–94.5%) and specificity was 77.8% (95% CI: 68.7%–86.8%); for carbapenem resistance, sensitivity was 77.8% (95% CI: 58.6%–97.0%) and specificity was 96.4% (95% CI: 93.4%–99.5%). Overall, nanopore sequencing is feasible for rapid detection of ceftriaxone and carbapenem resistance directly from positive blood cultures, although further optimization is needed to improve accuracy. IMPORTANCE Bloodstream infections can progress rapidly and require timely selection of effective antimicrobial therapy. However, conventional antimicrobial susceptibility testing typically requires 2–3 days, which may delay optimal treatment. In this study, nanopore sequencing detected key antimicrobial resistance genes in Escherichia coli and Klebsiella pneumoniae directly from positive blood cultures after approximately 1 h of sequencing. This approach could support earlier prediction of antibiotic resistance and help guide more timely treatment decisions for patients with serious infections. The study also identified important limitations, including incorrect predictions for ceftriaxone and carbapenem resistance in some samples. Overall, these findings highlight the potential of rapid DNA sequencing to improve the management of bloodstream infections, while emphasizing that further improvement in predictive accuracy is needed before routine implementation in clinical laboratories.
No takes yet. Share an insight, caveat, or question.
Tangkijwanichkul et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: